Dr. Patel is interested in translational research to improve diagnostics and therapeutics for breast cancer patients. Overall academic interests include nanoparticle technology, genomic instability, tumor targeting and personalized medicine. As with prior projects, he will strive to facilitate a bi-directional transfer of hypothesis-generating ideas between breast cancer clinic and scientific leaders across the DF/HCC program. He currently serves as an investigator on a number of breast cancer-specific clinical trials. In addition, is working to establish a pipeline for organoid development for the purpose of personalized therapeutic screening and interrogation of resistance mechanisms. Also, plans to collaborate with Dr. Gerburg Wulf’s lab to perform pre-clinical testing on a novel cell-penetrating antibody that targets DNA-repair deficient cells.